Results 141 to 150 of about 616,892 (193)

Identification of α-Synuclein Proaggregator: Rapid Synthesis and Streamlining RT-QuIC Assays in Parkinson's Disease. [PDF]

open access: yesACS Med Chem Lett, 2022
Takada F   +9 more
europepmc   +1 more source

When Proteins Go MAD-Misfolded, Amplified, Detected: Advances in α-Synuclein Pathophysiology and RT-QuIC Detection. [PDF]

open access: yesMol Neurobiol
Labajová N   +9 more
europepmc   +1 more source

Lessons from Tau RT–QuIC: Structure, Kinetics, and Drug Discovery

open access: yes
The aggregation of the microtubule–associated protein tau into filamentous inclusions is a hallmark of various neurodegenerative diseases collectively known as tauopathies. This group encompasses over 20 clinicopathological conditions, including Alzheimer’s disease (AD), which accounts for about 70% of dementia cases worldwide.
openaire   +1 more source

In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC. [PDF]

open access: yesNeurology, 2021
Donadio V   +12 more
europepmc   +1 more source

Creutzfeldt-Jakob disease in pregnancy: the use of modified RT-QuIC to determine infectivity in placental tissues. [PDF]

open access: yesPrion, 2021
Luk CC   +6 more
europepmc   +1 more source

RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease. [PDF]

open access: yesMov Disord, 2021
Mammana A   +7 more
europepmc   +1 more source

α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden [PDF]

open access: yes
INTRODUCTION: Amyloid beta and tau pathology are the hallmarks of sporadic Alzheimer's disease (AD) and autosomal dominant AD (ADAD). However, Lewy body pathology (LBP) is found in ≈ 50% of AD and ADAD brains.
Baiardi, Simone   +46 more
core  

Home - About - Disclaimer - Privacy